JP2015520165A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520165A5
JP2015520165A5 JP2015512903A JP2015512903A JP2015520165A5 JP 2015520165 A5 JP2015520165 A5 JP 2015520165A5 JP 2015512903 A JP2015512903 A JP 2015512903A JP 2015512903 A JP2015512903 A JP 2015512903A JP 2015520165 A5 JP2015520165 A5 JP 2015520165A5
Authority
JP
Japan
Prior art keywords
salt
compound
formula
process according
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512903A
Other languages
English (en)
Japanese (ja)
Other versions
JP6196294B2 (ja
JP2015520165A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/041687 external-priority patent/WO2013173779A1/en
Publication of JP2015520165A publication Critical patent/JP2015520165A/ja
Publication of JP2015520165A5 publication Critical patent/JP2015520165A5/ja
Application granted granted Critical
Publication of JP6196294B2 publication Critical patent/JP6196294B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512903A 2012-05-17 2013-05-17 アミノ酸化合物を製造するためのプロセス Active JP6196294B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261648534P 2012-05-17 2012-05-17
US61/648,534 2012-05-17
PCT/US2013/041687 WO2013173779A1 (en) 2012-05-17 2013-05-17 Process for making amino acid compounds

Publications (3)

Publication Number Publication Date
JP2015520165A JP2015520165A (ja) 2015-07-16
JP2015520165A5 true JP2015520165A5 (OSRAM) 2016-06-30
JP6196294B2 JP6196294B2 (ja) 2017-09-13

Family

ID=48483247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512903A Active JP6196294B2 (ja) 2012-05-17 2013-05-17 アミノ酸化合物を製造するためのプロセス

Country Status (21)

Country Link
US (1) US9278917B2 (OSRAM)
EP (1) EP2850054B1 (OSRAM)
JP (1) JP6196294B2 (OSRAM)
KR (1) KR102074535B1 (OSRAM)
CN (1) CN104520263B (OSRAM)
AU (1) AU2013262516B2 (OSRAM)
BR (1) BR112014028585B1 (OSRAM)
CA (1) CA2873658C (OSRAM)
ES (1) ES2668477T3 (OSRAM)
HR (1) HRP20180948T1 (OSRAM)
IL (1) IL235630A (OSRAM)
MA (1) MA37751B1 (OSRAM)
MX (1) MX350443B (OSRAM)
MY (1) MY171538A (OSRAM)
NZ (1) NZ702939A (OSRAM)
PL (1) PL2850054T3 (OSRAM)
RU (1) RU2643146C2 (OSRAM)
SG (1) SG11201407625WA (OSRAM)
SI (1) SI2850054T1 (OSRAM)
TR (1) TR201807444T4 (OSRAM)
WO (1) WO2013173779A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ702935A (en) 2012-05-17 2017-02-24 Genentech Inc Process for making hydroxylated cyclopentylpyrimidine compounds
ES2588878T3 (es) 2012-05-17 2016-11-07 Array Biopharma, Inc. Proceso para preparar compuestos de ciclopentilpirimidina hidroxilada
CA2873661C (en) 2012-05-17 2020-07-21 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
EP3719014A1 (en) 2012-05-17 2020-10-07 Genentech, Inc. Solid forms of an akt inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof
CN112898210B (zh) * 2013-11-15 2025-02-21 豪夫迈·罗氏有限公司 用于制备嘧啶基环戊烷化合物的方法
CA3190507A1 (en) * 2014-09-26 2016-03-31 F. Hoffmann-La Roche Ag Processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663327A (en) 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
JPH09506369A (ja) 1993-12-12 1997-06-24 アグロジーン・リミテッド 菌類感染から植物を保護するための新規方法
AU724216B2 (en) 1997-04-07 2000-09-14 Merck & Co., Inc. A method of treating cancer
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
US6376496B1 (en) 1999-03-03 2002-04-23 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
WO2001022963A1 (en) 1999-09-27 2001-04-05 Merck & Co., Inc. Method of preventing osteoporosis
WO2004108673A2 (en) 2003-06-09 2004-12-16 Boehringer Ingelheim International Gmbh Inhibitors of papilloma virus
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
UA95641C2 (xx) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
EP2209775A1 (en) 2007-10-09 2010-07-28 UCB Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
JP5734956B2 (ja) 2009-04-15 2015-06-17 アッヴィ・インコーポレイテッド 抗ウィルス化合物
EA020151B1 (ru) 2009-10-23 2014-09-30 Эли Лилли Энд Компани Ингибиторы akt и фармацевтические составы, их содержащие
US9050334B2 (en) 2010-07-16 2015-06-09 Innov88 Llc MIF inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
ES2588878T3 (es) 2012-05-17 2016-11-07 Array Biopharma, Inc. Proceso para preparar compuestos de ciclopentilpirimidina hidroxilada
CA2873661C (en) 2012-05-17 2020-07-21 Genentech, Inc. Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
CA2889855A1 (en) 2012-11-01 2014-05-08 Robert S. Katz Methods for treating fibromyalgia
CN105263910A (zh) 2013-02-18 2016-01-20 斯克利普斯研究所 具有治疗潜力的血管加压素受体调节剂
AU2014237198A1 (en) 2013-03-15 2015-11-05 Shifa Biomedical Corporation Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Similar Documents

Publication Publication Date Title
JP2015520165A5 (OSRAM)
RU2012103850A (ru) Би-арил-мета-пиримидиновые ингибиторы киназ
JP2011057686A5 (OSRAM)
JP2013521295A5 (OSRAM)
JP2009507932A5 (OSRAM)
JP2007269812A5 (OSRAM)
JP2011105738A5 (OSRAM)
JP2012507568A5 (OSRAM)
ME02558B (me) Inhibitori replikacije virusa gripa
JP2015518892A5 (OSRAM)
JP2007522220A5 (OSRAM)
JP2011513410A5 (OSRAM)
JP2011510079A5 (OSRAM)
EP4219465A3 (en) Prmt5 inhibitors and uses thereof
JP2011227454A5 (OSRAM)
JP2013500304A5 (OSRAM)
JP2015518837A5 (OSRAM)
AR083105A1 (es) Metodo para preparar 2-amino-n-(2,2,2-trifluoroetil)acetamida
MX2007007098A (es) Derivados de pirrol que tienen actividad antagonista del receptor crth2.
RU2014150991A (ru) Способ получения аминокислотных соединений
JP2007526383A5 (OSRAM)
EP2759540A3 (en) Beta-3 receptor ligands and their use in therapy
JP2006518752A5 (OSRAM)
JP2012511558A5 (OSRAM)
JP2009532434A5 (OSRAM)